Table of Contents
ISRN Obstetrics and Gynecology
Volume 2012, Article ID 576385, 10 pages
http://dx.doi.org/10.5402/2012/576385
Review Article

Ovarian Reserve Assessment for Infertility Investigation

GENESIS-Centre for Assistance in Human Reproduction, SHLS 716, Bloco “L”, Salas “L” 328/331, Centro Clínico Sul, Ala Leste, 70.390 Brasília, DF, Brazil

Received 6 November 2011; Accepted 30 November 2011

Academic Editors: C. Battaglia, J. G. Schenker, and F. Sharara

Copyright © 2012 Bruno Ramalho de Carvalho et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Leridon, “30 years of contraception in France,” Contraception Fertilite Sexualite, vol. 26, no. 6, pp. 435–438, 1998. View at Google Scholar · View at Scopus
  2. F. I. Sharara and R. T. Scott Jr., “Assessment of ovarian reserve and treatment of low responders,” Infertility and Reproductive Medicine Clinics of North America, vol. 8, no. 4, pp. 501–522, 1997. View at Google Scholar · View at Scopus
  3. A. Gougeon, “Regulation of ovarian follicular development in primates: facts and hypotheses,” Endocrine Reviews, vol. 17, no. 2, pp. 121–155, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. K. P. Tremellen, M. Kolo, A. Gilmore, and D. N. Lekamge, “Anti-müllerian hormone as a marker of ovarian reserve,” Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 45, no. 1, pp. 20–24, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. R. Fanchin, J. Taieb, D. H. M. Lozano, B. Ducot, R. Frydman, and J. Bouyer, “High reproducibility of serum anti-Müllerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status,” Human Reproduction, vol. 20, no. 4, pp. 923–927, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. F. J. Broekmans, J. Kwee, D. J. Hendriks, B. W. Mol, and C. B. Lambalk, “A systematic review of tests predicting ovarian reserve and IVF outcome,” Human Reproduction Update, vol. 12, no. 6, pp. 685–718, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. B. R. de Carvalho, A. C. J. D. S. Rosa e Silva, J. C. Rosa e Silva, R. M. dos Reis, R. A. Ferriani, and M. F. Silva de Sá, “Ovarian reserve evaluation: state of the art,” Journal of Assisted Reproduction and Genetics, vol. 25, no. 7, pp. 311–322, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. M. J. Faddy, R. G. Gosden, A. Gougeon, S. J. Richardson, and J. F. Nelson, “Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause,” Human Reproduction, vol. 7, no. 10, pp. 1342–1346, 1992. View at Google Scholar · View at Scopus
  9. J. Menken, J. Trussell, and U. Larsen, “Age and infertility,” Science, vol. 233, no. 4771, pp. 1389–1394, 1986. View at Google Scholar · View at Scopus
  10. T. Rowe, “Fertility and a woman's age,” The Journal of Reproductive Medicine, vol. 51, no. 3, pp. 157–163, 2006. View at Google Scholar · View at Scopus
  11. D. B. Dunson, B. Colombo, and D. D. Baird, “Changes with age in the level and duration of fertility in the menstrual cycle,” Human Reproduction, vol. 17, no. 5, pp. 1399–1403, 2002. View at Google Scholar · View at Scopus
  12. D. Schwartz and M. J. Mayaux, “Female fecundity as a function of age. Results of artificial insemination in 2193 nulliparous women with azoospermic husbands,” The New England Journal of Medicine, vol. 306, no. 7, pp. 404–406, 1982. View at Google Scholar · View at Scopus
  13. Centers for Disease Control and Prevention. Assisted Reproductive Technology (ART) Report: National Summary, 2009, http://apps.nccd.cdc.gov/art/Apps/NationalSummaryReport.aspx.
  14. F. Zegers-Hochschild, J. E. Schwarze, and V. Galdames, Eds., Red Latinoamericana de Reproducción Asistida, Registro Latinoamericano de Reproducción Asistida, 2008.
  15. A. Z. Steiner and R. J. Paulson, “Oocyte donation,” Clinical Obstetrics and Gynecology, vol. 49, no. 1, pp. 44–54, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. B. R. de Carvalho, I. D. O. Cabral, H. M. Nakagava, A. A. Silva, and A. C. P. Barbosa, “Woman's age and ovarian response in ICSI cycles,” Jornal Brasileiro de Reproducao Assistida, vol. 14, no. 1, pp. 24–27, 2010. View at Google Scholar · View at Scopus
  17. L. A. Cole, D. G. Ladner, and F. W. Byrn, “The normal variabilities of the menstrual cycle,” Fertility and Sterility, vol. 91, no. 2, pp. 522–527, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. L. Speroff and M. A. Fritz, “Female infertility,” in Clinical Gynecologic Endocrinology and Infertility, L. Speroff and M. A. Fritz, Eds., pp. 1015–1022, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 7th edition, 2005. View at Google Scholar
  19. P. van Zonneveld, G. J. Scheffer, F. J. M. Broekmans et al., “Do cycle disturbances explain the age-related decline of female fertility? Cycle characteristics of women aged over 40 years compared with a reference population of young women,” Human Reproduction, vol. 18, no. 3, pp. 495–501, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. N. A. Klein, A. J. Harper, B. S. Houmard, P. M. Sluss, and M. R. Soules, “Is the short follicular phase in older women secondary to advanced or accelerated dominant follicle development?” The Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 12, pp. 5746–5750, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Brodin, T. Bergh, L. Berglund, N. Hadziosmanovic, and J. Holte, “Menstrual cycle length is an age-independent marker of female fertility: results from 6271 treatment cycles of in vitro fertilization,” Fertility and Sterility, vol. 90, no. 5, pp. 1656–1661, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. T. Silberstein, D. T. MacLaughlin, I. Shai et al., “Müllerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology,” Human Reproduction, vol. 21, no. 1, pp. 159–163, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. C. B. Lambalk and C. H. de Koning, “Interpretation of elevated FSH in the regular menstrual cycle,” Maturitas, vol. 30, no. 2, pp. 215–220, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Al-Azemi, S. R. Killick, S. Duffy et al., “Multi-marker assessment of ovarian reserve predicts oocyte yield after ovulation induction,” Human Reproduction, vol. 26, no. 2, pp. 414–422, 2011. View at Publisher · View at Google Scholar · View at PubMed
  25. J. W. van der Steeg, P. Steures, M. J. C. Eijkemans et al., “Predictive value and clinical impact of basal follicle-stimulating hormone in subfertile, ovulatory women,” The Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 6, pp. 2163–2168, 2007. View at Publisher · View at Google Scholar · View at PubMed
  26. M. L. Haadsma, H. Groen, V. Fidler et al., “The predictive value of ovarian reserve tests for spontaneous pregnancy in subfertile ovulatory women,” Human Reproduction, vol. 23, no. 8, pp. 1800–1807, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. M. Ashrafi, T. Madani, A. Seirafi Tehranian, and F. Malekzadeh, “Follicle stimulating hormone as a predictor of ovarian response in women undergoing controlled ovarian hyperstimulation for IVF,” International Journal of Gynecology and Obstetrics, vol. 91, no. 1, pp. 53–57, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. M. Creus, J. Peñarrubia, F. Fábregues et al., “Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome,” Human Reproduction, vol. 15, no. 11, pp. 2341–2346, 2000. View at Google Scholar · View at Scopus
  29. E. R. Klinkert, F. J. M. Broekmans, C. W. N. Looman, J. D. F. Habbema, and E. R. Te Velde, “The antral follicle count is a better marker than basal follicle-stimulating hormone for the selection of older patients with acceptable pregnancy prospects after in vitro fertilization,” Fertility and Sterility, vol. 83, no. 3, pp. 811–814, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. M. Luna, L. Grunfeld, T. Mukherjee, B. Sandler, and A. B. Copperman, “Moderately elevated levels of basal follicle-stimulating hormone in young patients predict low ovarian response, but should not be used to disqualify patients from attempting in vitro fertilization,” Fertility and Sterility, vol. 87, no. 4, pp. 782–787, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. J. M. van Montfrans, A. Hoek, M. H. A. van Hooff, C. H. de Koning, N. Tonch, and C. B. Lambalk, “Predictive value of basal follicle-stimulating hormone concentrations in a general subfertility population,” Fertility and Sterility, vol. 74, no. 1, pp. 97–103, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. B. R. de Carvalho, A. C. J. D. S. Rosa-E-Silva, J. C. Rosa-E-Silva, R. M. D. Reis, R. A. Ferriani, and M. F. Silva de Sá, “Increased basal FSH levels as predictors of low-quality follicles in infertile women with endometriosis,” International Journal of Gynecology and Obstetrics, vol. 110, no. 3, pp. 208–212, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. A. H. Watt, A. T. R. Legedza, E. S. Ginsburg, R. L. Barbieri, R. N. Clarke, and M. D. Hornstein, “The prognostic value of age and follicle-stimulating hormone levels in women over forty years of age undergoing in vitro fertilization,” Journal of Assisted Reproduction and Genetics, vol. 17, no. 5, pp. 264–268, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. F. J. Hayes, J. E. Hall, P. A. Boepple, and W. F. Crowley, “Differential control of gonadotropin secretion in the human: endocrine role of inhibin,” The Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 6, pp. 1835–1841, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. N. A. Klein, P. J. Illingworth, N. P. Groome, A. S. McNeilly, D. E. Battaglia, and M. R. Soules, “Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles,” The Journal of Clinical Endocrinology and Metabolism, vol. 81, no. 7, pp. 2742–2745, 1996. View at Publisher · View at Google Scholar · View at Scopus
  36. D. A. Magoffin and A. J. Jakimiuk, “Inhibin A, inhibin B and activin A in the follicular fluid of regularly cycling women,” Human Reproduction, vol. 12, no. 8, pp. 1714–1719, 1997. View at Publisher · View at Google Scholar · View at Scopus
  37. C. K. Welt and A. L. Schneyer, “Differential regulation of inhibin B and inhibin A by follicle-stimulating hormone and local growth factors in human granulosa cells from small antral follicles,” The Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 1, pp. 330–336, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Tinkanen, M. Bläuer, P. Laippala, P. Tuohimaa, and E. Kujansuu, “Correlation between serum inhibin B and other indicators of the ovarian function,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 94, no. 1, pp. 109–113, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. D. B. Seifer, G. Lambert-Messerlian, J. W. Hogan, A. C. Gardiner, A. S. Blazar, and C. A. Berk, “Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome,” Fertility and Sterility, vol. 67, no. 1, pp. 110–114, 1997. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Eldar-Geva, E. J. Margalioth, A. Ben-Chetrit et al., “Serum inhibin B levels measured early during FSH administration for IVF may be of value in predicting the number of oocytes to be retrieved in normal and low responders,” Human Reproduction, vol. 17, no. 9, pp. 2331–2337, 2002. View at Google Scholar · View at Scopus
  41. J. Peñarrubia, S. Peralta, F. Fábregues, F. Carmona, R. Casamitjana, and J. Balasch, “Day-5 inhibin B serum concentrations and antral follicle count as predictors of ovarian response and live birth in assisted reproduction cycles stimulated with gonadotropin after pituitary suppression,” Fertility and Sterility, vol. 94, no. 7, pp. 2590–2595, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. S. L. Corson, J. Gutmann, F. R. Batzer, H. Wallace, N. Klein, and M. R. Soules, “Inhibin-B as a test of ovarian reserve for infertile women,” Human Reproduction, vol. 14, no. 11, pp. 2818–2821, 1999. View at Publisher · View at Google Scholar · View at Scopus
  43. J. B. Scheffer, D. M. Lozano, R. Frydman, and R. Fanchin, “Relationship of serum anti-Müllerian hormone, inhibin B, estradiol and FSH on day 3 with ovarian follicular status,” Revista Brasileira de Ginecologia e Obstetricia, vol. 29, no. 4, pp. 186–191, 2007. View at Google Scholar · View at Scopus
  44. M. McIlveen, J. D. Skull, and W. L. Ledger, “Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population,” Human Reproduction, vol. 22, no. 3, pp. 778–785, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. J. L. Frattarelli, P. A. Bergh, M. R. Drews, F. I. Sharara, and R. T. Scott Jr., “Evaluation of basal estradiol levels in assisted reproductive technology cycles,” Fertility and Sterility, vol. 74, no. 3, pp. 518–524, 2000. View at Publisher · View at Google Scholar · View at Scopus
  46. F. L. Licciardi, H. C. Liu, and Z. Rosenwaks, “Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization,” Fertility and Sterility, vol. 64, no. 5, pp. 991–994, 1995. View at Google Scholar · View at Scopus
  47. D. B. Smotrich, M. J. Levy, E. A. Widra, J. L. Hall, P. R. Gindoff, and R. J. Stillman, “Prognostic value of day 3 estradiol on in vitro fertilization outcome,” Fertility and Sterility, vol. 64, no. 6, pp. 1136–1140, 1995. View at Google Scholar · View at Scopus
  48. B. R. de Carvalho, A. C. J. D. S. Rosa E Silva, J. C. Rosa E Silva, R. M. Dos Reis, R. A. Ferriani, and M. F. Silva De Sá, “Use of ovarian reserve markers and variables of response to gonadotropic stimulus as predictors of embryo implantation in ICSI cycles,” Jornal Brasileiro de Reproducao Assistida, vol. 13, no. 3, pp. 26–29, 2009. View at Google Scholar · View at Scopus
  49. C. Fiçicioǧlu, T. Kutlu, E. Baglam, and Z. Bakacak, “Early follicular antimüllerian hormone as an indicator of ovarian reserve,” Fertility and Sterility, vol. 85, no. 3, pp. 592–596, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. R. Fanchin, L. M. Schonäuer, C. Righini, J. Guibourdenche, R. Frydman, and J. Taieb, “Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3,” Human Reproduction, vol. 18, no. 2, pp. 323–327, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. C. Weenen, J. S. E. Laven, A. R. M. von Bergh et al., “Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment,” Molecular Human Reproduction, vol. 10, no. 2, pp. 77–83, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. J. A. Visser and A. P. N. Themmen, “Anti-Müllerian hormone and folliculogenesis,” Molecular and Cellular Endocrinology, vol. 234, no. 1-2, pp. 81–86, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. A. L. L. Durlinger, P. Kramer, B. Karels et al., “Control of primordial follicle recruitment by anti-mullerian hormone in the mouse ovary,” Endocrinology, vol. 140, no. 12, pp. 5789–5796, 1999. View at Google Scholar · View at Scopus
  54. A. L. L. Durlinger, M. J. G. Gruijters, P. Kramer et al., “Anti-Müllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary,” Endocrinology, vol. 142, no. 11, pp. 4891–4899, 2001. View at Publisher · View at Google Scholar · View at Scopus
  55. N. di Clemente, B. Goxe, J. J. Remy et al., “Inhibitory effect of AMH upon the expression of aromatase and LH receptors by cultured granulosa cells of rat and porcine immature ovaries,” Endocrine, vol. 2, no. 6, pp. 553–558, 1994. View at Google Scholar · View at Scopus
  56. J. A. Visser, A. L. L. Durlinger, I. J. J. Peters et al., “Increased oocyte degeneration and follicular atresia during the estrous cycle in anti-Müllerian hormone null mice,” Endocrinology, vol. 148, no. 5, pp. 2301–2308, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. I. A. J. van Rooij, F. J. M. Broekmans, E. R. Te Velde et al., “Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve,” Human Reproduction, vol. 17, no. 12, pp. 3065–3071, 2002. View at Google Scholar · View at Scopus
  58. E. R. Te Velde and P. L. Pearson, “The variability of female reproductive ageing,” Human Reproduction Update, vol. 8, no. 2, pp. 141–154, 2002. View at Publisher · View at Google Scholar · View at Scopus
  59. M. J. G. Gruijters, J. A. Visser, A. L. L. Durlinger, and A. P. N. Themmen, “Anti-Müllerian hormone and its role in ovarian function,” Molecular and Cellular Endocrinology, vol. 211, no. 1-2, pp. 85–90, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Muttukrishna, H. McGarrigle, R. Wakim, I. Khadum, D. M. Ranieri, and P. Serhal, “Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?” An International Journal of Obstetrics and Gynaecology, vol. 112, no. 10, pp. 1384–1390, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  61. A. de Vet, J. S. E. Laven, F. H. de Jong, A. P. N. Themmen, and B. C. J. M. Fauser, “Antimüllerian hormone serum levels: a putative marker for ovarian aging,” Fertility and Sterility, vol. 77, no. 2, pp. 357–362, 2002. View at Publisher · View at Google Scholar · View at Scopus
  62. S. M. Nelson, M. C. Messow, A. M. Wallace, R. Fleming, and A. McConnachie, “Nomogram for the decline in serum antimüllerian hormone: a population study of 9,601 infertility patients,” Fertility and Sterility, vol. 95, no. 2, pp. 736–741, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. J. Van Disseldorp, M. J. Faddy, A. P. N. Themmen et al., “Relationship of serum antimüllerian hormone concentration to age at menopause,” The Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 6, pp. 2129–2134, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. E. A. Elgindy, D. O. El-Haieg, and A. El-Sebaey, “Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients,” Fertility and Sterility, vol. 89, no. 6, pp. 1670–1676, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. A. La Marca, G. Stabile, A. Carducci Artenisio, and A. Volpe, “Serum anti-Mullerian hormone throughout the human menstrual cycle,” Human Reproduction, vol. 21, no. 12, pp. 3103–3107, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  66. S. Tsepelidis, F. Devreker, I. Demeestere, A. Flahaut, C. Gervy, and Y. Englert, “Stable serum levels of anti-Müllerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women,” Human Reproduction, vol. 22, no. 7, pp. 1837–1840, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  67. S. L. Broer, B. W. J. Mol, D. Hendriks, and F. J. M. Broekmans, “The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count,” Fertility and Sterility, vol. 91, no. 3, pp. 705–714, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  68. T. H. Lee, C. H. Liu, C. C. Huang, K. C. Hsieh, P. M. Lin, and M. S. Lee, “Impact of female age and male infertility on ovarian reserve markers to predict outcome of assisted reproduction technology cycles,” Reproductive Biology and Endocrinology, vol. 7, article 100, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. L. G. Nardo, T. A. Gelbaya, H. Wilkinson et al., “Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization,” Fertility and Sterility, vol. 92, no. 5, pp. 1586–1593, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  70. S. Muttukrishna, H. Suharjono, H. McGarrigle, and M. Sathanandan, “Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients?” An International Journal of Obstetrics and Gynaecology, vol. 111, no. 11, pp. 1248–1253, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  71. R. Fadini, R. Comi, M. Mignini Renzini et al., “Anti-mullerian hormone as a predictive marker for the selection of women for oocyte in vitro maturation treatment,” Journal of Assisted Reproduction and Genetics, vol. 28, no. 6, pp. 501–508, 2011. View at Publisher · View at Google Scholar · View at PubMed
  72. A. La Marca, S. Giulini, A. Tirelli et al., “Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology,” Human Reproduction, vol. 22, no. 3, pp. 766–771, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  73. C. Gnoth, A. N. Schuring, K. Friol, J. Tigges, P. Mallmann, and E. Godehardt, “Relevance of anti-Mullerian hormone measurement in a routine IVF program,” Human Reproduction, vol. 23, no. 6, pp. 1359–1365, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  74. T. Irez, P. Ocal, O. Guralp, M. Cetin, B. Aydogan, and S. Sahmay, “Different serum anti-Müllerian hormone concentrations are associated with oocyte quality, embryo development parameters and IVF-ICSI outcomes,” Archives of Gynecology and Obstetrics, vol. 284, no. 5, pp. 1295–1301, 2011. View at Publisher · View at Google Scholar · View at PubMed
  75. D. B. Seifer, V. L. Baker, and B. Leader, “Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States,” Fertility and Sterility, vol. 95, no. 2, pp. 747–750, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  76. K. Majumder, T. A. Gelbaya, I. Laing, and L. G. Nardo, “The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 150, no. 2, pp. 166–170, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  77. C. Takahashi, A. Fujito, M. Kazuka, R. Sugiyama, H. Ito, and K. Isaka, “Anti-Müllerian hormone substance from follicular fluid is positively associated with success in oocyte fertilization during in vitro fertilization,” Fertility and Sterility, vol. 89, no. 3, pp. 586–591, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  78. S. Arabzadeh, G. Hossein, B. H. Rashidi, M. A. Hosseini, and H. Zeraati, “Comparing serum basal and follicular fluid levels of anti-Müllerian hormone as a predictor of in vitro fertilization outcomes in patients with and without polycystic ovary syndrome,” Annals of Saudi Medicine, vol. 30, no. 6, pp. 442–509, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  79. A. La Marca, G. Sighinolfi, D. Radi et al., “Anti-Müllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART),” Human Reproduction Update, vol. 16, no. 2, Article ID dmp036, pp. 113–130, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  80. S. M. Nelson, R. W. Yates, H. Lyall et al., “Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception,” Human Reproduction, vol. 24, no. 4, pp. 867–875, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  81. D. Navot, Z. Rosenwaks, and E. J. Margalioth, “Prognostic assessment of female fecundity,” The Lancet, vol. 2, no. 8560, pp. 645–647, 1987. View at Google Scholar · View at Scopus
  82. J. Kwee, R. Schats, J. McDonnell, J. Schoemaker, and C. B. Lambalk, “The clomiphene citrate challenge test versus the exogenous follicle-stimulating hormone ovarian reserve test as a single test for identification of low responders and hyperresponders to in vitro fertilization,” Fertility and Sterility, vol. 85, no. 6, pp. 1714–1722, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  83. R. C. Franco, R. A. Ferriani, M. D. Moura, R. M. Reis, R. A. Ferreira, and M. M. de Sala, “Evaluation of ovarian reserve: comparison between basal FSH level and clomiphene test,” Revista Brasileira de Ginecologia e Obstetrícia, vol. 24, no. 5, pp. 323–327, 2002. View at Google Scholar
  84. A. Maheshwari, A. Gibreel, S. Bhattacharya, and N. P. Johnson, “Dynamic tests of ovarian reserve: a systematic review of diagnostic accuracy,” Reproductive BioMedicine Online, vol. 18, no. 5, pp. 717–734, 2009. View at Publisher · View at Google Scholar · View at Scopus
  85. D. M. Ranieri, F. Quinn, A. Makhlouf et al., “Simultaneous evaluation of basal follicle-stimulating hormone and 17β- estradiol response to gonadotropin-releasing hormone analogue stimulation: an improved predictor of ovarian reserve,” Fertility and Sterility, vol. 70, no. 2, pp. 227–233, 1998. View at Publisher · View at Google Scholar · View at Scopus
  86. A. Ravhon, S. Lavery, S. Michael et al., “Dynamic assays of inhibin B and oestradiol following buserelin acetate administration as predictors of ovarian response in IVF,” Human Reproduction, vol. 15, no. 11, pp. 2297–2301, 2000. View at Google Scholar · View at Scopus
  87. D. J. Hendriks, F. J. M. Broekmans, L. F. J. M. M. Bancsi, F. H. de Jong, C. W. N. Looman, and E. R. te Velde, “Repeated clomiphene citrate challenge testing in the prediction of outcome in IVF: a comparison with basal markers for ovarian reserve,” Human Reproduction, vol. 20, no. 1, pp. 163–169, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  88. J. Kwee, M. W. Elting, R. Schats, P. D. Bezemer, C. B. Lambalk, and J. Schoemaker, “Comparison of endocrine tests with respect to their predictive value on the outcome of ovarian hyperstimulation in IVF treatment: results of a prospective randomized study,” Human Reproduction, vol. 18, no. 7, pp. 1422–1427, 2003. View at Publisher · View at Google Scholar · View at Scopus
  89. G. J. Scheffer, F. J. M. Broekmans, C. W. N. Looman et al., “The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age,” Human Reproduction, vol. 18, no. 4, pp. 700–706, 2003. View at Publisher · View at Google Scholar · View at Scopus
  90. L. F. J. M. M. Bancsi, F. J. M. Broekmans, M. J. C. Eijkemans, F. H. de Jong, J. D. Habbema, and E. R. Te Velde, “Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve,” Fertility and Sterility, vol. 77, no. 2, pp. 328–336, 2002. View at Publisher · View at Google Scholar · View at Scopus
  91. T. E. M. Verhagen, D. J. Hendriks, L. F. J. M. M. Bancsi, B. W. J. Mol, and F. J. M. Broekmans, “The accuracy of multivariate models predicting ovarian reserve and pregnancy after in vitro fertilization: a meta-analysis,” Human Reproduction Update, vol. 14, no. 2, pp. 95–100, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  92. M. L. Haadsma, A. Bukman, H. Groen et al., “The number of small antral follicles (2–6 mm) determines the outcome of endocrine ovarian reserve tests in a subfertile population,” Human Reproduction, vol. 22, no. 7, pp. 1925–1931, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  93. P. B. Maseelall, A. E. Hernandez-Rey, C. Oh, T. Maagdenberg, D. H. McCulloh, and P. G. McGovern, “Antral follicle count is a significant predictor of livebirth in in vitro fertilization cycles,” Fertility and Sterility, vol. 91, no. 4, supplement, pp. 1595–1597, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  94. A. Gibreel, A. Maheshwari, S. Bhattacharya, and N. P. Johnson, “Ultrasound tests of ovarian reserve; A systematic review of accuracy in predicting fertility outcomes,” Human Fertility, vol. 12, no. 2, pp. 95–106, 2009. View at Publisher · View at Google Scholar · View at Scopus
  95. B. Almog, F. Shehata, E. Shalom-Paz, S. L. Tan, and T. Tulandi, “Age-related normogram for antral follicle count: McGill reference guide,” Fertility and Sterility, vol. 95, no. 2, pp. 663–666, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  96. C. H. Syrop, J. D. Dawson, K. J. Husman, A. E. T. Sparks, and B. J. Van Voorhis, “Ovarian volume may predict assisted reproductive outcomes better than follicle stimulating hormone concentration on day 3,” Human Reproduction, vol. 14, no. 7, pp. 1752–1756, 1999. View at Publisher · View at Google Scholar · View at Scopus
  97. S. Bowen, J. Norian, N. Santoro, and L. Pal, “Simple tools for assessment of ovarian reserve (OR): individual ovarian dimensions are reliable predictors of OR,” Fertility and Sterility, vol. 88, no. 2, pp. 390–395, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  98. D. J. Hendriks, J. Kwee, B. W. J. Mol, E. R. te Velde, and F. J. M. Broekmans, “Ultrasonography as a tool for the prediction of outcome in IVF patients: a comparative meta-analysis of ovarian volume and antral follicle count,” Fertility and Sterility, vol. 87, no. 4, pp. 764–775, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  99. H. Tinkanen, M. Bläuer, P. Laippala, P. Tuohimaa, and E. Kujansuu, “Prognostic factors in controlled ovarian hyperstimulation,” Fertility and Sterility, vol. 72, no. 5, pp. 932–936, 1999. View at Publisher · View at Google Scholar · View at Scopus
  100. K. Elter, Z. N. Kavak, H. Gokaslan, and T. Pekin, “Antral follicle assessment after down-regulation may be a useful tool for predicting pregnancy loss in in vitro fertilization pregnancies,” Gynecological Endocrinology, vol. 21, no. 1, pp. 33–37, 2005. View at Publisher · View at Google Scholar · View at PubMed
  101. G. J. Scheffer, F. J. M. Broekmans, L. F. Bancsi, J. D. F. Habbema, C. W. N. Looman, and E. R. Te Velde, “Quantitative transvaginal two- and three-dimensional sonography of the ovaries: reproducibility of antral follicle counts,” Ultrasound in Obstetrics and Gynecology, vol. 20, no. 3, pp. 270–275, 2002. View at Publisher · View at Google Scholar · View at PubMed
  102. S. Kupesic, A. Kurjak, D. Bjelos, and S. Vujisic, “Three-dimensional ultrasonographic ovarian measurements and in vitro fertilization outcome are related to age,” Fertility and Sterility, vol. 79, no. 1, pp. 190–197, 2003. View at Publisher · View at Google Scholar · View at Scopus
  103. K. Jayaprakasan, B. Campbell, J. Hopkisson, J. Clewes, I. Johnson, and N. Raine-Fenning, “Establishing the intercycle variability of three-dimensional ultrasonographic predictors of ovarian reserve,” Fertility and Sterility, vol. 90, no. 6, pp. 2126–2132, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  104. D. K. C. Chui, N. D. Pugh, S. M. Walker, L. Gregory, and R. W. Shaw, “Follicular vascularity-the predictive value of transvaginal power Doppler ultrasonography in an in-vitro fertilization programme: a preliminary study,” Human Reproduction, vol. 12, no. 1, pp. 191–196, 1997. View at Google Scholar · View at Scopus
  105. M. F. Costello, S. M. Shrestha, P. Sjoblom et al., “Power doppler ultrasound assessment of the relationship between age and ovarian perifollicular blood flow in women undergoing in vitro fertilization treatment,” Journal of Assisted Reproduction and Genetics, vol. 23, no. 9-10, pp. 359–365, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  106. S. M. Shrestha, M. F. Costello, P. Sjoblom et al., “Power doppler ultrasound assessment of follicular vascularity in the early follicular phase and its relationship with outcome of in vitro fertilization,” Journal of Assisted Reproduction and Genetics, vol. 23, no. 4, pp. 161–169, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  107. B. R. de Carvalho, A. C. Japur De Sá Rosa-e-Silva, J. C. Rosa-e-Silva, R. M. Dos Reis, R. A. Ferriani, and M. F. Silva De Sá, “Anti-müllerian hormone is the best predictor of poor response in ICSI cycles of patients with endometriosis,” Clinical and Experimental Obstetrics and Gynecology, vol. 38, no. 2, pp. 119–122, 2011. View at Google Scholar